Corporate Social Responsibility

Corporate Social Responsibility

Corporate social responsibility is fundamental to the Viatris mission. We work to advance responsible and sustainable operations and leverage our collective expertise to empower people to live healthier at every stage of life, recognizing that our actions affect the stakeholders and communities we serve.

Because good health matters to everyone, everywhere

Read the report

We believe that everyone deserves to live a healthy life. With only about half of the global population able to receive essential health services – a figure further exacerbated by the COVID-19 pandemic – there is much to be done to ensure sustainable access to medicines worldwide. Our inaugural Sustainability Report aims to continue introducing Viatris as a new kind of healthcare company, including our commitments to stakeholders as we seek to empower people worldwide to live healthier at every stage of life.

Viatris 2020 Sustainability Report

Viatris 2020 Sustainability Report Fact Sheet

A letter from CEO Michael Goettler

A partner for sustainable development

At Viatris, our efforts to increase access to healthcare through strong leadership and strategic partnerships are critical in helping to reduce barriers to good health and have the potential to leave a lasting, positive impact on patients, families and communities worldwide.

Because of the purposeful and active role that we believe companies must play in this effort, we support the UN Global Compact and the global sustainable development agenda for 2030, as articulated by the United Nations in the adoption of the Sustainable Development Goals (SDGs) in 2015.

Our mission and business model directly contribute to SDG 3: Good Health and Well-Being, among others. By leveraging our diverse portfolio, global footprint and strategic partnerships, we have the potential to make a significant positive contribution in addressing the ongoing battle against infectious diseases and the global rise in the incidence of noncommunicable diseases (NCDs) as well as impacting key issues such as reproductive and women’s health. Highlights from 2020 include:

>80

billion doses sold

165+

countries and territories reached

5X

Our antiretroviral products reached 5X as many HIV patients as the branded originators combined

>500

million doses of medicine donated

60

medicines on the WHO list of prequalified products*

^{*including cross-listed approvals, as of March 23, 2021}

Impacting the future

The following efforts will continue to be vital to delivering on our mission and achieving a positive lasting impact on society:

Our Response to the Crisis in Ukraine

As a global healthcare company, our priorities during the humanitarian crisis in Ukraine and neighboring countries are protecting the safety and well-being of our colleagues, supporting impacted communities and doing our best to ensure access to essential medicines regardless of geography or circumstance.

Progressing our vision for good health

We know that meeting diverse needs in a complex global healthcare environment requires sustained commitment, innovation and action. We also understand that not only what we do, but how we do it, impacts billions around the world.

Viatris’ role in the fight against COVID-19

We are committed to doing our part to support public health needs amid the pandemic. Our priorities remain protecting the health and safety of our workforce, producing critically needed medicines, deploying our resources and expertise through potential prevention and treatment efforts and supporting the communities in which we operate.

Learn more about our role in the fight against COVID-19

Serving patients

People in more than 165 countries around the world rely on our products, and we're committed to increasing patient access to quality, affordable medicines, regardless of geography or circumstance.

Learn more about us

Learn more about our commitment to patient health

Ensuring patient safety and quality

Protecting patient health by ensuring the quality and safety of our products is at the heart of how we operate across our network. Every step of our development, manufacturing and monitoring processes - from product development to sourcing of raw materials to producing finished dosage forms and delivering that product - is grounded in this commitment.

Learn more about our commitment to safety and quality

Engaging and supporting our employees

At Viatris, we embrace diverse viewpoints and nurture collaboration. We will work to ensure a safe, productive and positive work environment that fosters inclusion, integrity and mutual respect for all.

Learn more about working at Viatris
Learn more about our commitment to our employees

Strengthening our environmental responsibility

We are committed to environmentally responsible conduct and have policies and procedures to support our work to systematically and diligently minimize our environmental footprint. Our integrated, comprehensive approach focuses on managing our water, air emissions, waste, climate change and energy impact.

Learn more about our commitment to environmental health

Strengthening global public health policy

We consider it our duty to advocate for policies that advance knowledge and education, reduce barriers to treatment access to achieve better health for patients and unlock value for health systems. We emphasize a long-term view, maximizing the benefits of both innovation and competition to sustain the delivery of high quality, affordable medicine to patients everywhere, today and tomorrow.

Learn more about our commitment to policy solutions
Learn more about our commitment to global public health

Supporting communities

We are committed to helping create healthier and more sustainable communities worldwide. We work with global and local partners on a variety of philanthropic efforts, including supporting education, community programs and better access to treatment.

Learn more about our commitment to community health

Enhancing supplier relationships

At Viatris, we rely on suppliers and business partners to deliver affordable and accessible products to our customers and ultimately to patients. Building strong and long-term relationships helps to reduce risk, enhances resilience and ensure a high quality and reliable supply.

Viatris is a member of the PSCI

Learn more about enhancing supplier relationships

Acting with integrity

As we explore new opportunities for Viatris, we are committed to conducting all aspects of our business with integrity and upholding responsible business practices in our own operations as well as in external engagements.

We have clear procedures to mitigate risks and support employees in their everyday work life, including but not limited to interaction with healthcare professionals, marketing and communication, anti-corruption and fair competition, partnerships and supplier relations.

Learn more about corporate governance

Building partnerships

As a trusted Partner of Choice^™ for healthcare systems, professionals, and organizations, we are dedicated to expanding access to medicine for patients throughout our communities and around the world. We are committed to providing the tools, guidance, healthcare education and outreach necessary to connect patients to trusted, high quality medications.

Learn more about our partnerships

Viatris was officially formed on Nov. 16, 2020, through the combination of Mylan and Upjohn, a legacy division of Pfizer. We recently published our inaugural 2020 Sustainability Report. As we continue to develop Viatris’ program, including goals and partnerships, we look forward to sharing our progress and publishing additional resources on our website.